ON
← Back to feed
20 Minutes logo🏛️ Politics
France🏛️ PoliticsCenter6 hr. ago

Talc and cancer: Johnson & Johnson offers $5.5 billion to settle legal battle

Johnson & Johnson has proposed a settlement of $5.5 billion to resolve ongoing lawsuits alleging that its talc-based products cause cancer. The lawsuits claim that the company's talcum powder products contain asbestos, which is linked to ovarian cancer. The proposed settlement would cover claims from thousands of plaintiffs who allege they developed cancer due to long-term exposure to the product. The proposal comes after years of litigation and regulatory scrutiny, with some cases having been dismissed but others continuing through the legal process.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

1 reports

20 Minutes logo20 MinutesIndependentCenter6 hr. ago
Talc and cancer: Johnson & Johnson offers $5.5 billion to settle legal battle

Johnson & Johnson has proposed a settlement of $5.5 billion to resolve ongoing lawsuits alleging that its talc-based products cause cancer. The lawsuits claim that the company's talcum powder products contain asbestos, which is linked to ovarian cancer. The proposed settlement would cover claims from thousands of plaintiffs who allege they developed cancer due to long-term exposure to the product. The proposal comes after years of litigation and regulatory scrutiny, with some cases having been dismissed but others continuing through the legal process.

Bias read (Center): The article presents factual information about a corporate legal settlement without overtly endorsing or criticizing either side. It reports on the financial terms of the proposed agreement and the nature of the allegations against Johnson & Johnson, without taking a clear ideological stance. While

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories